Russel J. Reiter honored with Lifetime Achievement Award.

The organizing committee of the Drug Research & Development Conference announces that Russel J. Reiter, Distinguished Professor at the University of Texas Health Science Center at San Antonio, received the Lifetime Achievement Award. This recognition honors his significant contributions to biomedical science and pharmaceutical research.

The award presentation occurred during the Drug Research & Development Conference held February 23–25, 2026, in San Diego, California. The event convened leading scientists, clinicians, and industry experts globally to examine recent drug discovery and development advancements.

A career in melatonin biology

Professor Reiter is recognized internationally for his pioneering research on melatonin biology, circadian rhythms, oxidative stress, and aging. His decades of groundbreaking work has substantially advanced understanding of melatonin’s influence on human health, disease prevention, and therapeutic innovation.

With over a thousand scientific publications and considerable global impact, Professor Reiter’s research continues influencing modern neuroendocrinology, antioxidant biology, and translational medicine. The award acknowledges his scientific leadership, discoveries, and biomedical research influence.

About the Drug Research & Development Conference

The conference assembles leading scientists, researchers, clinicians, and industry innovators to examine pharmaceutical science breakthroughs, translational medicine, and therapeutic innovation advancements. It functions as a worldwide collaboration platform advancing next-generation drug discovery and development.

See photos from Drug R&D 2026 →